Loss of PPARG Expression Is Common in CpG Island Methylator Phenotype-Low (CIMP-Low) Colorectal Cancer

被引:0
|
作者
Shima, K.
Nosho, K.
Chen, L.
Fuchs, C. S.
Ogino, S.
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
738
引用
收藏
页码:167A / 168A
页数:2
相关论文
共 50 条
  • [41] DIFFERENCES IN RISK FACTORS FOR SERRATED COLORECTAL POLYPS ACCORDING TO CPG ISLAND METHYLATOR PHENOTYPE (CIMP) STATUS
    Burnett-Hartman, A. N.
    Newcomb, P. N.
    Mandelson, M. T.
    Wurscher, M. A.
    Makar, K. W.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S231 - S231
  • [42] Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer
    Lee, Michael S.
    McGuffey, Elizabeth J.
    Morris, Jeffrey S.
    Manyam, Ganiraju
    Baladandayuthapani, Veerabahdran
    Wei, Wei
    Morris, Van K.
    Overman, Michael J.
    Maru, Dipen M.
    Jiang, Zhi-Qin
    Hamilton, Stanley R.
    Kopetz, Scott
    BRITISH JOURNAL OF CANCER, 2016, 114 (12) : 1352 - 1361
  • [43] Intermediate- and Low-Methylation Epigenotypes Do Not Correspond to CpG Island Methylator Phenotype (Low and -Zero) in Colorectal Cancer
    Karpinski, Pawel
    Walter, Michael
    Szmida, Elzbieta
    Ramsey, David
    Misiak, Blazej
    Kozlowska, Joanna
    Bebenek, Marek
    Grzebieniak, Zygmunt
    Blin, Nikolaus
    Laczmanski, Lukasz
    Sasiadek, Maria M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (02) : 201 - 208
  • [44] CpG Island Methylator Phenotype and Prognosis of Colorectal Cancer in Northeast China
    Li, Xia
    Hu, Fulan
    Wang, Yibaina
    Yao, Xiaoping
    Zhang, Zuoming
    Wang, Fan
    Sun, Guizhi
    Cui, Bin-Bin
    Dong, Xinshu
    Zhao, Yashuang
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [45] CpG island methylator phenotype (CIMP): A novel biomarker to predict new therapy for breast cancer
    Yu, Y.
    Feng, W.
    Shen, L.
    Rosen, D. G.
    Liu, J.
    Shen, Y.
    Hunt, K. K.
    Orlandi, R.
    Issa, J. -P.
    Bast, R. C. J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 121 - 122
  • [46] Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
    Shailesh Mahesh Advani
    Pragati Shailesh Advani
    Derek W. Brown
    Stacia M. DeSantis
    Krittiya Korphaisarn
    Helena M. VonVille
    Jan Bressler
    David S. Lopez
    Jennifer S. Davis
    Carrie R. Daniel
    Amir Mehrvarz Sarshekeh
    Dejana Braithwaite
    Michael D. Swartz
    Scott Kopetz
    BMC Cancer, 19
  • [47] Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
    Advani, Shailesh Mahesh
    Advani, Pragati Shailesh
    Brown, Derek W.
    DeSantis, Stacia M.
    Korphaisarn, Krittiya
    VonVille, Helena M.
    Bressler, Jan
    Lopez, David S.
    Davis, Jennifer S.
    Daniel, Carrie R.
    Sarshekeh, Amir Mehrvarz
    Braithwaite, Dejana
    Swartz, Michael D.
    Kopetz, Scott
    BMC CANCER, 2019, 19 (01)
  • [48] CpG island methylator phenotype (CIMP) and P53 methylation patterns in Puerto Rican Hispanic colorectal cancer patients
    Castro, Cristina I.
    Lacourt, Mercedes Y.
    Bernabe, Raul Ft
    Cruz-Correa, Marcia R.
    CANCER RESEARCH, 2010, 70
  • [49] ASSOCIATION BETWEEN CPG ISLAND METHYLATOR PHENOTYPE (CIMP) AND TREATMENT RESPONSE OF FOLFIRI WITH CETUXIMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)
    Kim, S. H.
    Park, K. H.
    Shin, S. J.
    Lee, K. Y.
    Kim, T. I.
    Kim, N. K.
    Rha, S. Y.
    Roh, J. K.
    Ahn, J. B.
    ANNALS OF ONCOLOGY, 2012, 23 : 41 - 42
  • [50] CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies
    Ogino, S.
    Cantor, M.
    Kawasaki, T.
    Brahmandam, M.
    Kirkner, G. J.
    Weisenberger, D. J.
    Campan, M.
    Laird, P. W.
    Loda, M.
    Fuchs, C. S.
    GUT, 2006, 55 (07) : 1000 - 1006